FDA Package on User Fees, Baby Formula Advances to Full Senate (1)

A key Senate committee overseeing the FDA advanced a proposal to reauthorize the industry user fees that help fund the agency, paving the way for a vote in the full chamber.

The Senate Health, Education, Labor, and Pensions Committee Tuesday voted 13-9 in support of sweeping bipartisan legislation (S. 4348) that would revamp the Food and Drug Administration’s accelerated approval pathway and boost oversight on lab-developed tests. The committee adopted a substitute amendment that includes several measures to improve infant formula oversight after a recall at an Abbott facility propelled a nationwide shortage.

“This is the most important, ...